Status: Recruiting
Comparison of Efficacy in SBRT of Large HCC With or Without TACE
The study aims to compare efficacy and adverse reactions of large hepatocellular carcinoma participants (5-10cm) who receive stereotactic body radiation therapy with or without transcatheter arterial chemoembolization.The investigators will optimize the combined treatment schedule of SBRT for hepatocellular carcinoma participants by comparing overall survival rates, progression-free survival rates and local control and adverse reaction occurrence rates in the two groups.
Participants needed: 100
Trial details
Age: 30-80Biological sex: AllType: ObservationalSponsor: Beijing 302 HospitalUpdated: Jun 27, 2023Locations: 1
Eligibility criteria
primary HCC diagnosed by a surgeon and/or radiologist and oncologist according t... [+8]
tumor thrombus; [+2]